Site Logo

PRECLINICAL STUDIES

PRECLINICAL STUDIES
STUDY NAME
TRAUMA – LARGE ANIMAL LONG BONE REPAIR STUDY
Evaluation of AMP2 coated ReBOSSIS in the chronic caprine tibial defect model
Sheep Illustration
Logos
Study Objects
STUDY OBJECTIVE
1
Tibial Defect

5 cm goat tibial bone critical size defect

2
OsteoAdapt regenerative therapeutic upon implantation
Rebossis AMP2 Tibial Defect Rebossis AMP2
STUDY OUTCOMES
STRONG DOSE DEPENDENT BONE REGENERATION

Dose-dependent bone regeneration was demonstrated over the full defect and showed complete bridging in the optimal conditions?

Bone Formation

COMPLETE REGENERATION WITH PRECISION

Complete Regeneration Precision Complete Regeneration
Bone 0
Bone 1
Bone 2
Bone 3
OUR NOVEL TECHNOLOGY

AMP2 has beaten the standard of care in evey preclinical study conducted to date. Our platform technology unleashes the regenerative potential of injured tissues.

LEARN MORE
PARTNER WITH US

We are headquartered in Frederick, Maryland with other locations in Boston, Orlando, and Memphis.

We believe in the power of teams and have several partnerships that are advancing new therapies. If you are interested in exploring a partnership, contact us.